Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?

Overview of attention for article published in Hematology Journal, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 1 public wall post.

The approval of the anti-CD19 chimeric antigen receptor (CAR) T-cell product tisagenlecleucel (Kymriah®) by the FDA and the EMA…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.